Important notice

The information on this page is intended for use only by knowledgeable and experienced professionals working in the healthcare and medical industry. By continuing, you automatically confirm that you are a professional working for a healthcare provider in a European country.

Yes No
18F-Florbetaben

Neuraceq

Description

Neuraceq is a radiopharmaceutical indicated for Positron Emission Tomography (PET) imaging of β-amyloid neuritic plaque density in the brains of adult patients with cognitive impairment who are being evaluated for Alzheimer’s disease (AD) and other causes of cognitive impairment. Neuraceq should be used in conjunction with a clinical evaluation.
A negative scan indicates sparse or no plaques, which is not consistent with a diagnosis of AD. For the limitations in the interpretation of a positive scan see sections 4.4 and 5.1.

Specifications

Active Substance:

Florbetaben (18F)

Pharmacotherapeutic group:

Other diagnostic radiopharmaceutical for tumor detection

Form / Packaging:

Solution for Injection 300 MBq/mL

Downloadable File